Skip to main content
Your shopping cart is empty
Your Cart is Empty

Please note that this website is a separate website than the UHMS website. Your login credentials for the UHMS website will not work here. If you have not created an account on this website yet, please do so by clicking the "Log in" button and then "Register" at the bottom of the pop-up dialog.

2023 UHMS Annual Scientific Meeting

2023 UHMS Annual Scientific Meeting June 16-18, 2023 The primary goal of the Undersea and Hyperbaric Medical Society ASM is to provide a forum for professional scientific growth and development to the participants.  The meeting provides a basis for exchange of ideas, both scientific and pract ...Read more

  • Course Description
  • Course Credits

2023 UHMS Annual Scientific Meeting

June 16-18, 2023

The primary goal of the Undersea and Hyperbaric Medical Society ASM is to provide a forum for professional scientific growth and development to the participants.  The meeting provides a basis for exchange of ideas, both scientific and practical, among physicians, researchers, and other health professionals.  It affords an opportunity for participants to meet and interact with past and present leaders of the Society, and to become active in societal affairs.

*Partial credit is not offered for this educational program. If you claimed CE credit for the in-person program, you are not eligible to receive credit again for the enduring material program.

Estimated time to complete this activity: 17 hours

Termination Date: May 21, 2027


  • Non-Member: $382.50
  • Regular UHMS Member: $297.50
  • Associate UHMS Member: $212.50


Opening Ceremony / Welcome - UHMS President: Pete Witucki, MD

Kindwall Keynote: Hyperbaric Oxygen and Inflammatory Bowel Disease: Parambir Singh Dulai, MBBS

Plenary: International Panel: Oxygen: How much, How Often: Jacek Kot, MD; Gerardo Bosco, MD; Tino Balestra, MSc, PhD

B11: Association between number of hyperbaric oxygen therapy sessions and neurocognitive outcomes of acute carbon monoxide poisoning; Yong Sung Cha, MD, PhD

B28: A randomized, double-blind trial of hyperbaric oxygen for persistent symptoms after brain injury (HYBOBI-2): Lindell Weaver, MD

A3: Sex differences in susceptibility to central nervous system oxygen toxicity: Matthew S. Makowski, MD

Plenary: UHM Fellows: Top Articles in Hyperbaric Medicine: Claire Ellis, MD: Duke Fellow

Plenary: Session B: Reimbursement-Revenue Management Panel, Helen Gelly, MD; Ian Grover, MD

B5: National outcomes of hyperbaric oxygen in necrotizing soft tissue infections: William Toppen, MD

B6: A Randomized Trial of Preoperative Hyperbaric Oxygen (HBOT) Before Pancreaticoduodenectomy: Enrico Camporesi, MD

B7: Age and diabetes increase refractive changes over time with hyperbaric oxygen: Jay Buckey, MD

Lambertsen Keynote: SEALAB: Kevin Hardy, DSc hc

Plenary: Session C: Decompression Panel: Stephen Thom, MD (Microparticles); David Doolette, PhD; (VGE Measurement); Greg Murphy (USN Heliox Tables)

C55: Diving into decompression sickness-resistant rat’s gene expression of genes involved in antioxidant mechanisms and mitochondrial biogenesis; Emmanuel Dugrenot, PhD

C56: Real-time deployment feasibility of deep learning VGE detection models for ultrasound echocardiograms; Arian Azarang, PhD

C54: Preliminary qualitative assessment of bubbles inside porcine lymph nodes, imaged by ultrasound after a provocative dive profile: Josh Currens, BS

C52: Elevations of inflammatory biomarkers in closed circuit SCUBA divers parallel those in DCS models: Stephen Thom, MD

C53: A Novel Method for Observing Gaseous Nitrogen In Vivo and Ex Vivo Using Radioactive Nitrogen-13: Edward Ashworth, PhD

C58: Effects of oxygen prebreathing on tissue nitrogen content under normobaric and hyperbaric conditions; Edward Ashworth, PhD

Plenary: Session D: Diving Medicine Research Panel: Richard Moon, MD; Jay Dean, MD; Jim Chimiak, MD

D65: Preliminary evidence that fourteen days of apnea and hypoxia exposures reduces circulating pro-inflammatory microparticles: Zachary Schlader, PhD

D66: Analysis of chest radiographs from navy SEAL (Sea Air Land) candidates developing pulmonary symptoms while swimming: Two different patterns of what previously has been described as pulmonary: Peter Lindholm, MD, PhD

D67: Arterial PCO2 during submersed prone exercise suggests attenuation of hypercapnia after respiratory muscle training: Nicholas Bartlett

Plenary: UHM Fellows: Top articles in Undersea Medicine: Matthew Makowski, MD - Duke Fellow

Plenary: ADCI Medical Guidelines Update: Tony Alleman, MD

Davis Keynote: Historical perspective: Safety development; John Feldmeier, DO

E100: Rapid discharge of rechargeable lithium-ion batteries at 1ATA and 3ATA: Chae Bliss, CHT

E92: GO/NO GO: A tool to eliminate the guesswork in determining which items may be allowed in a hyperbaric chamber: Jeff Mize RRT, CHT, UHMSADS

E98: A solution for clinical hyperbaric facilities to easily standardize, track and document routine safety inspections: Checklist-based digital task manager: Tiffany Hamm BSN, RN, ACHRN, CWS, UHMSADS

F123: Pneumorrhachis and pneumocephalus following epidural anesthesia for labor and delivery: A case report and systematic review: Michelle Cao, BA

Plenary: Pitfalls in Hyperbaric Facility Safety Management: Francois Burman, PR ENG, BSC (ENG), MSC.

Plenary: Active Shooter and the Implications with Pressurized Vessel Environment/Operations.  Julio Garcia, RN, Jacquline Hocking, CHT; Geness Koumandakis, CHT, RRT

Plenary: The first deep hydrogen rebreather dive; an adventure in applied gas physiology: Simon Mitchell, MD

Plenary: Review of Emergency Decompression - bailouts: Sean Hardy, MD

E88: A Case to Support the Routine Monitoring and Analysis of Breathing Gases Provided to the BIBS Line from Vendor Provided K Cylinder Storage: John Sullivan, CHT

E89: Barriers to 24/7 Availability and Emergent Clinical Capabilities of Hyperbaric Medicine Facilities: A Large-Scale Survey Study: John McGlynn, MD

E90: Strengths and Weaknesses of Monoplace vs Multiplace Chambers for Hyperbaric Critical Care: Ian Millar, MBBS

New Indication: Hyperbaric Treatment for Femoral Aseptic Bone Necrosis, Enrico Camporesi, MD

F102: Hyperbaric oxygen therapy in the management of upper extremity frostbite injury: A case series: Olayinka David Ajayi, MD, MPH

F103: Fluorescence microangiography as a novel tool to identify and monitor ischemia in crush injury: Margot Samson, MD

F104: Acute Central Retinal Artery Occlusion from Cosmetic Filler Injection: Casey Smith, MD


Designation Statements:

  • Physician CME:  The Undersea and Hyperbaric Medical Society designates this enduring material for a maximum of 17 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • Nursing CEU:  Approved license types: Advanced Registered Nurse Practitioner; Clinical Nurse Specialist; Licensed Practical Nurse; Registered Nurse; Certified Nursing Assistant; Respiratory Care Practitioner Critical Care; Respiratory Care Practitioner Non-Critical Care; Registered Respiratory Therapist; Certified Respiratory Therapist.  This enduring material is approved for 17 contact hours by the Florida Board of Registered Nursing Provider #50-10881.
  • NBDHMT: This enduring material is approved for 11 Category A and 6 Category B credit hours by National Board of Diving and Hyperbaric Medical Technology, P.O. Box 758, Pelion, SC 29123.
    • NBDHMT Accreditation Statement: For CHT recertification purposes, the NBDHMT requires a minimum of nine of the minimum 12 required Category A credits relate directly to any combination of hyperbaric operations, related technical aspects and chamber safety.

Accreditation Statement: The Undersea and Hyperbaric Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Disclaimer: The information provided at this CME activity is for Continuing Medical Education purposes only. The lecture content, statements or opinions expressed however, do not necessarily represent those of the Undersea and Hyperbaric Medical Society.

Full Disclosure Statement: All faculty members and planners participating in continuing medical education activities sponsored by Undersea and Hyperbaric Medical Society are expected to disclose to the participants any relevant financial relationships with ineligible companies. Full disclosure of faculty and planner relevant financial relationships will be made at the activity. 

Disclosures: All individuals in control of content for this educational activity with their relevant financial relationship disclosed are listed below (if applicable). An individual who refuses to disclose relevant financial relationships will be disqualified from being in control of educational content at any time, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity.

Financial relationships are relevant if the following three conditions are met for the individual who will control content of the education:

  • A financial relationship, in any amount, exists between the person in control of content and an ineligible company.
  • The content of the education is related to the products of an ineligible company with whom the person has a financial relationship.
  • The financial relationship existed during the past 24 months

“None of the individuals in control of content (planners/faculty/reviewers/authors) for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”

There are no relevant financial relationships with ineligible companies to mitigate for this educational activity.

Thank you to the following commercial supporters for our 2023 UHMS Annual Scientific Meeting:

  1. Freedom Hyperbaric Systems/BaroServ: Satchel Sponsor
  2. Fink Engineering: Silver Sponsor $4,500
  3. Hyperbaric Modular Systems: Bronze Sponsor $3,500